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Abstract
The purpose of the current study was to investigate depression and health care use in patients with
sickle cell disease (SCD). Forty-four adults with SCD were interviewed and data from 43
participants, both with (n = 11) and without (n = 32) depression, were used for further analyses.
Data from one potential subject were excluded on the basis of diagnosis. The full evaluation
included the Structured Clinical Interview for DSM-III-R Disorders (SCID) and the Center for
Epidemiologic Studies–Depression Scale (CES-D), as well as measures of psychosocial and
behavioral functioning. Good between-instrument agreement was found between the self-report
and interview-based measures of depression. However, the functioning data did not entirely
support the use of a more stringent cutoff score on the CES-D. Findings suggest that the purpose
of the evaluation should be factored into the decision-making process when determining which
cutoff score should be utilized (i.e. what is the cost–benefit ratio for false-positives vs. false-
negatives). A series of hierarchical regression analyses supported the finding that disease severity
alone does not explain the level of functioning displayed by patients. More importantly, the
patient’s perceived functioning was the best indicator of health care use within a 1-year period.
Furthermore, specific interventions that target negative thinking and distorted cognitions, as well
as provide psychoeducation, such as cognitive–behavioral therapy, need to be further explored
within this population.
INTRODUCTION
Studies of health care and related costs estimate that at any given time between 2%–10% of
the population meets criteria for depression. However, nearly half of those who seek
treatment do not receive an intervention from a mental health care specialist but rather from
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a primary care physician (1). Depression may often go undetected by primary care
physicians (2-4). Undiagnosed, depression in a medically ill population may result in an
excess of psychosocial and behavioral dysfunction that may be incorrectly attributed to
medical illness. Consequently, the symptoms targeted for treatment and subsequent
outcomes may be affected.
Interest in the effects of depression on functioning and treatment outcome has increased
considerably in specific disease populations, such as cancer (5-7) and neurological disorders
(8-10). However, other chronic illnesses have received much less attention; one such illness
is sickle cell disease (SCD). Sickle cell disease affects 1 in 400 African–Americans (11) and
consists of a group of genetically similar disorders characterized by the production of
abnormal hemoglobin. This abnormality episodically results in the sickling of red blood
cells (12). The accumulation of sickled cells in the circulatory system prevents oxygen from
reaching the intended tissue or organ, which may result in tissue death and organ failure.
Acute and unpredictable painful episodes are presumed to result from the ischemic tissue
injury. In general, SCD is a serious and painful disease with no cure at this time. However,
prevention and maintenance treatment may allow patients to cope more effectively with the
disease (13).
Differences between SCD and previously studied diseases may be categorized into two
areas: (a) disease characteristics and (b) demographics. In terms of disease characteristics,
SCD has both chronic and acute elements. The chronic and unpredictable painful episodes
that accompany SCD, as well as serious acute and chronic complications (e.g. stroke, acute
chest syndrome, etc.) have an onset that begins in early childhood. This differentiates SCD
from a number of illnesses that are either acute in onset and brief in duration, or are chronic
but have a much later onset.
Demographically, SCD in the United States occurs almost exclusively among African–
Americans (13). Several studies have documented significant differences between African–
Americans and non-African–Americans in the prevalence of depression and subsequent
treatment-seeking behavior (14,15).
Depression and SCD
Until recently, studies of adults with SCD and psychosocial functioning have focused
primarily on either nonspecific psychological distress (16-18) or depressive symptoms (19),
using measures which were either not specific to depression or not standardized for a
medically ill population (i.e. cutoff scores were not adjusted to account for increases in
somatic symptoms associated with the disease). Higher rates of psychological distress
(estimated between 56% and 77%) (16-18) have been reported in adults with SCD compared
to other outpatient primary care populations (estimated between 11% and 36%) (20).
However, these studies may actually have reported the prevalence of general distress and not
depression, or more likely, prevalence rates which were inflated by somatic symptoms.
A recent study from our research program (21) examined the prevalence of depressive
symptomatology in patients with SCD using the Center for Epidemiologic Studies–
Depression Scale (CES-D) (22). The CES-D is a widely-used screening measure of
depression that has been validated recently for use in patients with some medical illnesses
(7,23,24). In this study, 43% of the 440 patients studied were found to have significant
levels of depressive symptomatology using the standard, traditional cutoff score. This
percentage dropped substantially to only 18% when the more stringent cutoff score
recommended for those with medical illness (25) was used. Thus, a large percentage of
individuals (25%) have unexplained symptoms that may be attributable to either the disease
process or to depression. We concluded from these results that future studies were needed to
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determine the most valid cutoff score on self-report measures of depression in patients with
SCD.
Purpose of the Present Study
The primary purpose of the present study was to evaluate a range of cutoff scores on the
CES-D by comparing responses from the self-report measure to diagnoses determined
through structured clinical interviews, thus examining the sensitivity and specificity of the
CES-D. The purpose of this analysis is to pragmatically examine the consequences for
researchers and clinicians interested in SCD in choosing a particular cutoff score on a self-
report measure of depressive symptoms.
We thought it useful to determine the appropriate cutoff on the CES-D because it is brief,
easily administered during a clinical visit, and is widely accepted as a valid screening
measure of depression. The Structured Clinical Interview for DSM diagnoses (SCID) (26)
was used as the basis for comparison to determine sensitivity and specificity, since it has
been generally assumed that diagnostic interviews are the “gold standard” for determining
the presence of depression (27). We also included measures of psychosocial and behavioral
functioning to determine external validity (i.e. are different cutoff scores associated with
significant differences in actual functioning). Moreover, we investigated the relationship of
depression with health care use.
The specific hypotheses of the present study were: (a) that a more stringent cutoff score on a
self-report measure of depressive symptoms would increase accuracy in the detection of
depression when compared with the standard score for this measure, (b) the adjusted cutoff
score would increase the efficacy of the measure to discriminate between functionally
impaired and nonimpaired patients, and (c) that depression would contribute independent
and significant variance in psychosocial and behavioral functioning beyond that attributable
to the disease process associated with SCD. In contrast to previous studies of patients with
SCD (28,29) in which psychological distress and depression were conceptualized as




Forty-four patients recruited from the Duke University–University of North Carolina
Comprehensive Sickle Cell Center were interviewed and data from 43 participants were
used for further analyses. Data from one potential subject were excluded on the basis of
diagnosis (i.e. patient met criteria for bipolar disorder which was part of the exclusionary
criteria). The study consisted of 18 males and 25 females, all of whom were African–
American. Depressed and nondepressed subjects (based upon the clinical interview) did not
differ significantly demographically. The mean educational level for those depressed versus
nondepressed was 13.9 years (SD = 2.4) versus 13.1 years (SD = 1.4), and the mean age for
depressed versus nondepressed was 34.8 years (SD = 7.5) versus 35.1 years (SD = 10.9).
Forty percent of the participants who were not depressed were single, compared to 14% of
the depressed participants. Twelve percent of the participants who met criteria for
depression were unemployed, compared with 28% of the nondepressed participants.
Design and Procedures
In this cross-sectional within-group study, patients were contacted either by telephone or
during clinic visits and asked to participate in an assessment of the health and functioning of
patients with SCD. Consent was then obtained, followed by an interview to obtain
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demographic, disease severity data. The self-report measures of depression and psychosocial
and behavioral functioning were then completed, followed by the diagnostic interview. The
self-reported depression measure was completed prior to the diagnostic interview to prevent
undue influence by the interview process and assure that the interviewer was blind to the
patient’s self-assessment prior to the diagnostic interview.
Collateral Information and Follow-Up
To address the possible influence of affect on memory (i.e. depressed patients reporting an
increased number of negative events in relation to their depressed mood), collateral data
were collected from informants including either a spouse, parent, or close friend (30). These
data were elicited regarding the patient’s psychosocial and behavioral functioning. At the
time of the initial contact, the name of a significant other or close friend was solicited and a
telephone interview was arranged with the confidant. Following the initial assessment,
patients were provided self-monitoring records to assess health care use and disease-specific
functioning over a 6-week period in order to address the difference in time frame between
the health care use and psychosocial and general functioning measures.
MEASURES
Depression
The Structured Clinical Interview for DSM-III-R (SCID) (26) is a semistructured interview
designed for use with either patient (SCID-P) or nonpatient (SCID-NP) populations to
derive Diagnostic and Statistical Manual-III-Revised (DSM-III-R) diagnoses by trained
clinicians.3 Individual items are rated as present, sub-threshold, clearly not present, or there
is insufficient information provided to make the decision. For the current study, the SCID-
NP (which is intended for use in research in nonpatient applications) was administered by an
advanced clinical psychology graduate student (M.G.) trained in the use of the SCID. Each
diagnostic interview was either audiotaped or videotaped. Tapes were reviewed and
discussed with a Ph.D. level clinician (K.G.) to resolve diagnostic issues. Only the sections
of the interview on affective disorders were used for diagnoses and assessed both current
disorders (within the past month) and lifetime history. The sections on bipolar disorder and
psychotic disorder were administered for exclusionary purposes. Data from the SCID are by
definition categorical and were analyzed as depressed and nondepressed.4
A multisite study of test–retest reliability of the SCID examining current diagnoses of major
depression and dysthymia based on K revealed values of .64 and .40, respectively (31).
These values indicate moderate to low agreement but were comparable to those found with
other structured diagnostic instruments, such as the Diagnostic Interview Schedule (32).
Other prior studies of interrater reliability for the SCID (33,34) which have used the
aforementioned procedures have found good overall agreement (K = .74) and (K = .72) and
significantly better agreement on the diagnostic category of major depression (K = .93).
Interrater Reliability—An independent rater (M.F.), an advanced graduate student in
psychology trained in the use of the SCID, reviewed 20% of the interviews. Interviews were
randomly selected for review (i.e. based on a random numbers table). The coefficient K was
3Although the SCID for DSM-III-R (27) was utilized for this study, criteria for both major depressive disorder and dysthymic disorder
remained the same for Diagnostic and Statistical Manual-IV (DSM-IV) and subsequently findings are applicable to DSM-IV defined
depression and will heretofore be addressed as DSM-IV (28) defined depression.
4Due to the limited sample size, patients who met criteria for “Depression, Not Otherwise Specified (NOS)” were included in the
analyses. Depression, NOS criteria included reporting at least one “A criteria” symptom such as dysphoric mood or anhedonia and no
more than three “B criteria” symptoms for a consecutive 2-week period. A diagnosis of major depression requires at least five “B
criteria” symptoms.
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subsequently calculated to determine interrater reliability for the diagnostic interview. Only
one diagnostic disagreement occurred and the tape was reviewed and resolution was
obtained. Good overall agreement was found (K = .84).
Depressive Symptoms
The Center for Epidemiologic Studies Depression Scale (CES-D) (22) is a 20-item measure,
developed to detect symptoms of depression in the general population. Each item is scored
from 0 (almost never) to 3 (almost always). The measure assesses depressive symptoms
reported over a 1-week period. Total scores may range from 0 to 60. CES-D items were
derived from a compilation of items from other well-validated depression scales. Four
factors have been derived from the CES-D (e.g. dysphoria, positive affect, and somatic and
interpersonal factors), with most of the emphasis on dysphoric mood. A cutoff score of 16 is
typically used to discriminate between depressed and nondepressed mood. The validity and
reliability of the CES-D are well established and generalize across demographic subgroups
(22,35). Items from the CES-D were summed and a total score reported. The scores were
analyzed both as continuous data (i.e. as a measure of severity) and as categorical data (i.e.
depressed or nondepressed) with higher scores indicating increased severity of depression.
Functioning
Psychosocial—The Social Adjustment Scale-Self Report (SAS-SR) (36) is a self-report
measure of social impairment which consists of 42 questions which measure performance in
six areas of functioning: housework, work outside the home or student-related activities;
social and leisure activity; extended family relations; and marital role as a spouse, parent,
and family member. The measure assesses functioning within a 2-week time frame.
Questions are rated on a 5-point scale from 1 to 5, with higher scores indicating greater
impairment.
A test of concurrent validity of the SAS-SR (based on a sample of 482 respondents from a
community sample 292 psychiatric outpatients) indicated the ability to discriminate between
acute depressives, alcoholics, schizophrenics, and nondepressed respondents. Acceptable
internal consistency (mean alpha coefficient = .74) and moderate test–retest reliability (mean
coefficient = .80) have also been established (37).
Behavioral—General behavioral functioning was assessed with the Symptom Impact
Profile (SIP) (38). The SIP is regarded as a standard measure of functional status and quality
of life. The 12 SIP subscales include ambulation, mobility, body care, movement, social
interaction, communication, emotional behavior, alertness, eating, work, sleep, rest, and
household management and are used to derive general functioning data. Respondents were
asked to check each item that described their behavior and related to their health status on a
given day. Responses were summed and a composite score computed. SIP scores may range
between 0 and 100 with higher scores indicating more impaired functioning.
Convergent validity for the SIP with other well-established functional status measures such
as the Arthritis Impact Measurement Scale (AIMS), the Functional Status Index, and the
Health Assessment Questionnaire are high (.87, .73, and .78, respectively). Good
discriminant validity was also found when comparing the SIP with measures of pain, and
psychological and clinical measures.
Disease Specific—Functioning specifically related to SCD was assessed with the
Structured Pain Interview (39). The interview assesses three pain-related variables: pain
status, activity reduction, and self-reported health care utilization during the time period
consisting of the 12 months prior to the interview. Painful episodes are defined as pain
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which cannot be attributed to any cause other than vaso-occlusion secondary to SCD. Pain
status was assessed based upon the severity, frequency, and duration of painful episodes
experienced. Severity was determined by a rating scale ranging from 0 to 10, with zero equal
to no pain and 10 equal to pain as bad as it can be. Reductions in activity were assessed
using a visual analogue rating scale which ranges from 0% (do not cut back at all) to 100%
(cut back completely). Activity reduction was reported as the mean percentage reduction
(0% to 100%) in the amount of time spent engaging in either work, socializing, or household
chores due to SCD crisis. Health care use was determined based upon the total number of
emergency room visits, hospitalizations, and phone calls/visits to physicians.
A prior study of the reliability and validity of the Structured Pain Interview utilized a 2-
week self-monitoring record (29). Significant Pearson product-moment correlations were
reported for pain ratings, r(41) = .36, p < .02, and health care contacts, r(41) = .59, p < .
0001. Patient-reported health care use was also compared with patient medical records.
Comparisons of patientreported contacts and documented medical records also indicated
significant correlations, r(88) = .31, p < .003. Interrater reliability for the Structured Pain
Interview was determined in a separate study (40) comparing reports from adolescents with
parent reports. Correlations for pain intensity, pain duration, emergency room visits, number
of hospitalizations, and number of physician calls/visits were all significant (Pearson rs were
reported between .42–.92). Thus, no additional reliability or validity data were collected as
part of the current study.
Disease Severity
No standardized measure has been developed to assess the severity of SCD. However, there
are two measures which allow for the quantification of level of severity: phenotype and
number of complications (28,29). Phenotype is determined by hemoglobin electrophoresis.
Although there is variability within type, Sickle Cell Anemia (SS) is thought to be the most
severe (12). The total number of complications (e.g. leg ulcers, renal complications, aseptic
necrosis, ocular complications, right upper quadrant syndrome, skeletal and joint pain,
swelling of hands/feet, acute anemia, sepsis/febrile, seizures, strokes, acute chest syndrome,
and priapism) were assessed by the Structured Pain Interview.
Demographics
A brief assessment of demographic information was conducted to collect data on age, sex,
marital status, level of education, and socioeconomic status.
RESULTS
Three sets of analyses were performed. The first set of analyses examined the sensitivity and
specificity of the CES-D in comparison with the diagnostic interview using logistic
regression to investigate the use of different cutoff scores within this specific population
(SCD). The second set of analyses examined between-group differences using t-tests
(depressed versus nondepressed) by functioning (i.e. group classification determined by
adjusted and nonadjusted cutoff score). The third set of analyses were hierarchical
regression analyses designed to determine the amount of variance in functioning and health
care use explained by self-reported depression, after controlling for demographic and
disease variables.
Based upon the SCID, 25.6% (11/43) of the participants met criteria for depression. Means
and standard deviations for all measures by SCID diagnostic category are presented in Table
1. Significant between-group differences on severity of depression on the CES-D and in
functioning (both psychosocial and behavioral) were found. Although depressed patients
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reported a greater number of painful episodes, emergency room visits, and acute
complications, these findings did not reach statistical significance.
Sensitivity and Specificity Data
Sensitivity and specificity of the CES-D were examined through comparison with the SCID,
to determine whether an increase in the cutoff score would improve the ability to detect
depression in patients with SCD. A logistic regression was performed using the SCID
diagnosis as the binomial dependent variable and the CES-D score as the independent
variable. A classification table that generated sensitivity and specificity values was
subsequently created. The raw probabilities from the table were converted into cutoff scores
using the formula, X = [ln (l/p – 1) – alpha]/beta, where p is the probability value, alpha is
the intercept parameter estimate, and beta is the parameter estimate for the CES-D. A range
of consecutive cutoff scores between the traditional score of 16 and the proposed adjusted
cutoff score of 27 were examined (see Table 2). No specific score derived provided an
optimal false positive and false negative value that distinguished it entirely. For example, the
traditional cutoff score of 16 provides good sensitivity (i.e. 81.8%) and excellent specificity
(i.e. 90.6%) but would falsely identify 25% of patients examined as depressed. Table 2
further illustrates these findings. There were six cases where disagreement was found using
the cutoff score of 16. Most of these disagreements were false positives, where the
diagnostic interview classified the patient as nondepressed but the patient met criteria for
depression by self-report. The CES-D scores for the false positives ranged from 16 to 24. In
contrast, the proposed adjusted cutoff score of 27 would eliminate false positives entirely
but would increase the percent of false negatives to 13.5%. Cutoff scores between 17 and 26
tend to provide less sensitivity than the original score but result in improved specificity.
Variability in Functioning Based Upon Different CES-D Cutoff Scores
Differences in functioning by diagnostic category as assessed by the CES-D, using either the
traditional or adjusted cutoff scores, were determined through the use of t-tests. The two
groups (i.e. those above and below the cutoff score on the CES-D) were compared on a
series of general behavioral, psychosocial, and disease-specific functioning variables. These
data are presented in Table 3. Significant differences in general behavioral and psychosocial
functioning were found for the traditional cutoff score but not for the proposed adjusted
score. However, no significant differences were found for disease-specific functioning for
either cutoff score. Further examination of Table 3 indicates that the increase in cutoff score
results in higher mean scores on almost all of the functioning variables for the nondepressed
group, while the means for the depressed group remained relatively stable.
Hierarchical Analyses of Depression and Functioning
The functioning data were subsequently analyzed using hierarchical regression analyses to
test several models. Each hierarchical model entered an independent variable or set of
variables into the equation in individual steps according to a predetermined, theoretically
driven hierarchy. Step one included demographic variables (e.g. age, sex), step two included
disease severity (e.g. phenotype, number of complications), and step three included level of
depressive symptomatology based upon the CES-D.
Table 4 indicates that the full hierarchical models tested for behavioral functioning, F(5, 29)
= 5.74, p < .0013, and psychosocial functioning, F(5, 41) = 11.21, p < .0001, were
significant. Individual factors that predicted behavioral functioning included sex (i.e. men
reported more impaired functioning than women), the number of complications experienced
(i.e. more complications were associated with more impaired functioning), and increased
severity of depression as assessed by the CES-D (see Table 4). The number of complications
reported accounted for 22% of the variance in behavioral functioning, while depression
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accounted for 28%. Depression was the only variable that predicted psychosocial
functioning as assessed by the SAS-SR and accounted for 55% of the variance, F = 49.96, p
< .0001. Each of the full models predicting functioning were significant, but age and SCD
type did not predict functioning in either model.
The overall model of disease-specific functioning on the Structured Pain Interview (again,
see Table 4) examining reductions in time spent on chores/household tasks was also
significant and accounted for 27% of the variance, F(5, 40) = 2.53, p < .05. In addition,
effects for both depression (i.e. increased severity) and sex (i.e. men reported more impaired
functioning than women) were also found in that model. Again, neither age nor SCD
severity expressed as either type or number of complications were significant. The analyses
examining reductions in work and social activity were not significant.
An examination of the relationship between depression and health care use did not indicate a
significant direct effect for depression (assessed by the CES-D) with the measures of health
care use. Instead, emergency room use, hospitalizations, and visits to the doctor were all
significantly correlated with the number of acute complications experienced r(43) = .45, .51,
and .51, p < .01, respectively. Acute complications were significantly correlated with
impaired behavioral functioning, r(30) = .37, p < .04, and behavioral functioning was
positively correlated with the severity of depression as assessed by the CES-D, r(30) = .53, p
< .0025.
Collateral Data
Fifty-six percent (24/43) of the informants contacted provided information (Pearson rs for
the SIP and SAS-SR were r = .52, p < .01, and r = .41, p < .05, respectively. Significant
differences were not found between participants and their informants on any of the
variables, although participants generally reported more frequent episodes, 10.12 per year
(12.68) versus 8.25 (10.62), and greater duration of pain, 3.23 days (3.79) versus 2.29 days
(1.69); whereas informants generally reported slightly greater impairment, 70.83% reduction
(22.39) versus 65.05% reduction (25.80) for household chores, and 67.08% reduction
(24.39) versus 65.41% reduction (28.41) for social functioning.
Follow-Up Data
Completed health care self-monitoring records were returned by 37% (16/43) of the
participants. A positive and significant relationship was found between the initial evaluation
and total health care contacts reported (r = .55, p < .04).
DISCUSSION
Many individuals with sickle cell disease are well-adjusted psychologically despite the
severity of their medical illness. However, findings from the present study along with those
of prior studies (21) indicate that depression can be a problem for many patients. The
incidence of depression in adults with SCD in comparison with other illness populations had
previously been limited by exclusive use of self-report symptom measures. Higher rates of
psychological distress (estimated between 56% and 77%) (16-18) were subsequently
reported in adults with SCD compared to other outpatient primary care populations
(estimated between 11% and 36%) (20). More recent studies in adults (41) have found
comparable levels of psychological distress between women with SCD, breast cancer, and
insulin-dependent diabetes mellitus (IDDM). In contrast, meta-analyses of developmental
findings (42) indicate that children with chronic medical illnesses are at only slightly
increased risk for developing depressive symptoms and do not meet clinical criteria any
more often than their non-ill counterparts. Nevertheless, children with SCD do appear to be
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at greater risk for developing depression than children with other comparable disorders such
as cancer, cystic fibrosis, and diabetes.
Sensitivity and Specificity
Concurrent validity of the CES-D with the SCID indicated good between-instrument
agreement in identifying depressive symptomatology. However, the traditional cutoff score
of 16 on the CES-D resulted in the misclassification of 12% of the sample. Most of the
“misses” were false positives, wherein the patient initially reported a number of depressive
symptoms and met criteria for depression on the CES-D but then subsequently did not meet
criteria for depression during the interview. This concurs with the literature on depression in
medically ill populations (4,25), suggesting the need for higher cutoff scores to reduce the
number of false positives, which may be a reflection of patients reporting symptoms of
medical illness and not psychological symptoms. However, the cutoff score of 27, suggested
by prior research (4,25), was not entirely supported in this sample. The functioning data
associated with the increased cutoff score resulted in no significant distinction between the
group classified as depressed and the nondepressed group. Notably, when the cutoff score
was raised to 27 on the CES-D, the nondepressed group’s functioning became equally
impaired as the depressed group, and more variability appears to have been introduced into
the nondepressed sample as a result of the increase in the cutoff score.
One explanation for the discrepancy between the self-reported depression findings and the
diagnostic interview with regard to false positives is that it may reflect a subclinical disorder
of brief duration that has not persisted for the continuous 2-week period necessary to meet
criteria for a diagnosis of depression in the Diagnostic and Statistical Manual (DSM)
system. Another possible explanation is that patients may have acknowledged experiencing
individual depressive symptoms but were uncomfortable accepting the label of “depression”
which is utilized during the diagnostic interview.
If the former is true, the fact that the patient has reported significant symptomatology,
regardless of its etiology, is important because findings concerning the development of
depression indicate that episodes of depression tend to have an insidious onset that begins
initially at subclinical levels and progressively worsen, if untreated, into full episodes (43).
However, if the explanation is the latter, psychoeducation as a targeted intervention may be
needed to address patient concerns regarding the label of depression and its meaning.
The findings examining between-group differences on clinically defined depression,
determined by diagnostic interview and self-report, indicate greater impairment in both
psychosocial and behavioral functioning in the depressed group. Similar to prior research on
adjustment (18), depressed patients reported more complications and more painful episodes
than the nondepressed patients, but in neither the previous study, nor the current one, did
these findings reach significance.
Interestingly, it has been assumed that diagnostic interviews are the “gold standard” for
determining the presence of depression, whereas self-report measures are considered less
accurate. However, the current study found better agreement in terms of functioning with the
self-report measure, providing additional support for the validity of the CES-D as a means of
brief assessment of depression in the primary care setting.
Good psychological adjustment, a nonspecific term referring to the lack of symptoms
necessary to meet criteria for an ongoing clinically defined disorder, has been found to be
associated with low levels of perceived stress, infrequent use of negative thinking, and
passive adherence as coping strategies and family functioning characterized by
supportiveness, low conflict, and control (18). Conversely, negative thinking and passive
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adherence have been associated with greater severity of painful episodes and more frequent
hospitalizations and emergency room visits (13). Both of the aforementioned studies of
SCD, however, measured elements of depression but not the clinically defined syndrome
that most clinicians are likely to examine.
Therefore, determining which is more important, sensitivity or specificity, may be a
judgment that is best determined by the individual clinician or researcher. While the
reduction of false positives (falsely categorizing a patient as depressed) has received most of
the attention in the literature (2,4,25), false negatives (missing someone who is indeed
depressed) should be of equal concern. Additional assessment of a patient who self-reports a
false positive will likely reveal the error. However, overlooking false negatives will likely
result in the undertreatment or mistreatment of depression and its subsequent consequences
(44).
Depression and Functioning
An examination of the relationship between depression and health care use in the form of
doctor visits, emergency room use, and hospitalizations did not reveal a direct relationship.
Instead, a more complex relationship between depression and health care use, influenced by
degree of functional impairment was found. Specifically, similar to prior studies of health
care use in patients with SCD (29), the number of doctor visits reported was predicted by
disease severity (defined as a combination of both SCD type and the number of
complications reported).
However, even with disease severity controlled, behavioral functioning still predicted the
number of doctor visits reported and accounted for a significant proportion of the variance.
While the number of doctor visits reported did not differ by diagnostic category according to
the SCID interview, a functioning by group difference was found for self-reported
depression. Patients who self-reported as depressed also reported twice as many doctor visits
in a year as the nondepressed group. The combined factors of disease severity and
functioning explained almost half of the variance in doctor visits.
In conclusion, the current study suggests that there appears to be an overemphasis placed on
cutoff scores on measures of depression. However, improved agreement between self-report
and interview-based measures of depression are not necessarily accompanied by improved
agreement with level of functioning. As found in several prior studies (13,29,39), even
severity of disease alone does not explain the level of functioning displayed by a given
patient. Instead, health care utilization appears to be significantly affected by perceived
functioning. To the extent that depression contributes to worsening of functioning beyond
that attributable to the disease process, one area of intervention which may be targeted in
terms of reducing high health care utilization may be the assessment and treatment of
depression in this population. However, an alternative explanation that cannot be ruled out
by the current study has been suggested by McCrae and Lumley (45), suggesting that
negative thinking and somatic awareness (i.e. bodily hypervigilance) may be components of
the same construct, namely negative affectivity. Nevertheless, these findings would still
suggest that psychological factors, and not simply disease severity, should be targeted for
intervention.
Limitations of the current study include the need for behavioral observation of functioning
by trained observers to rate level of functioning independently. While patients and their
nominated informants generally agree on functioning, neither is an unbiased observer. This
step would further clarify any differences in actual versus perceived functioning and the
subsequent impact on health care utilization. Further, the addition of a control comparison
group without SCD could provide baseline rates of depression and functioning in a
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comparable demographic sample. However, the inclusion of patients with SCD, both with
and without depression, in the current study may partially address this issue, since all
subjects were similar with regard to disease status and demographics such as race, age, and
education.
A separate issue of concern is in relation to the differing time periods under assessment by
the various measures in the study. Behavioral functioning and health care use are constructs
that are assessed over a 12-month time frame necessarily, since as the current data reveal,
outpatient samples of SCD patients do not utilize health care services or experience painful
episodes very often within a 2-week period (the time frame for assessing the psychosocial
measures). However, recent findings suggest that even with treatment, the median duration
of a first episode of depression is 22 weeks (46). Therefore, with or without treatment, there
is an expected stability of mood for a significant portion of the assessment period utilized for
the assessment of health care use and functioning. However, to address this matter, a 6-week
prospective follow-up of daily functioning was included to assess whether there were
significant correlations between the initial evaluation of health care use and follow-up
contacts reported. Although a significant relationship was found, measures with comparable
assessment time frames would better address this problem.
Similarly, the use of a cross-sectional design prohibits the interpretation of the current
finding of decreased functioning in depressed subjects as causal, since decreased functioning
as a result of the disease process could just as well contribute to the onset of depression.
However, this possibility is attenuated by the fact that, regardless of the etiology of the
decreased functioning, it is associated with both increased health care use and risk of
developing a more chronic course of depression.
Prior research in first-visit psychiatric patients (47,48) have compared the CES-D with a
semistructured interview (e.g. the Psychiatric Initial Screening for Affective Disorders
[PISA]) in a Japanese sample. The comparison of alternative scoring methods, using
receiver operating characteristic analysis (ROC), indicated that the traditional scoring
method was most appropriate for this sample. An ROC analysis is an alternative and
sometimes preferable strategy that examines the ability of a measure to distinguish signal
(sensitivity) from noise (specificity) and should be considered in future studies.
A final constraint through which all findings from this work must be interpreted is the
limited number of patients with depression (n = 11) in this sample. A larger study of
depressed patients with SCD may reflect a more representative distribution of functioning
and health care use and allow for more elaborate analysis, such as an ROC. The current
study provides preliminary evidence of impaired functioning that should serve as the basis
for a follow-up investigation that utilizes oversampling for depression to address this
limitation.
In short, this work suggests future intervention studies that target clinical and subclinical
symptoms of depression in patients with SCD are needed. Findings from our prior studies
indicate that training in cognitive–behavioral pain coping skills leads to important benefits
for patients with SCD (49,50). Specifically, interventions that target coping skills,
depressive cognitions, and provide psychoeducation (39,51) may well prevent the onset of a
pattern of chronic depression secondary to disease and further improve the quality of life for
patients.
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TABLE 2
Sensitivity and Specificity of the CES-D for Traditional and Adjusted Cutoff Scores
Score Sensitivity % Specificity % False Positive % False Negative %
16* 81.8 90.6 25.0 6.6
17 72.7 90.6 27.3 9.4
18 72.7 93.8 20.0 9.1
19 72.7 93.8 20.0 9.1
20 63.6 93.8 22.2 11.8
21 63.6 93.8 22.2 11.8
22 63.6 96.9’ 12.5 11.4
23 63.6 96.9 12.5 11.4
24 63.6 96.9 12.5 11.4
25 54.5 96.9 14.3 13.9
26 54.5 96.9 14.3 13.9
27 54.5 100.00 0.0 13.5
Note: Sensitivity and specificity are provided for each cutoff score on the CES-D between 16 and 27 in addition to the number of false positives
and false negatives generated by that score in this sample. (Example: Score of 25 would only correctly detect about 55% of cases but would rule
out most noncases).
*
Refers to the traditional cutoff score of 16.
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